Austco Healthcare Ltd (ASX: AHC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Austco Healthcare Ltd Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $146.15 million
P/E Ratio 19.69
Dividend Yield 0.00%
Shares Outstanding 374.75 million
Earnings per share 0.016
Dividend per share 0.00
Year To Date Return -17.72%
Earnings Yield 5.08%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

  • Austco Healthcare Ltd (ASX: AHC)
    Latest News

    a woman
    ⏸️ Investing

    3 hot healthcare stocks to make your returns healthier

    Sirtex Medical Limited (ASX:SRX), Azure Healthcare Ltd (ASX:AZV) and Cochlear Limited (ASX:COH) should get a boost from the weaker Aussie…

    Read more »

    a woman
    ⏸️ Investing

    These 3 stocks could shoot the lights out

    Is it time to buy these outperforming small-caps? A quick look at Nanosonics Limited (ASX:NAN), Azure Healthcare Ltd (ASX:AZV), and…

    Read more »

    a woman
    ⏸️ Investing

    Why Azure Healthcare Ltd looks a great buy at current prices

    Azure Healthcare Ltd (ASX:AZV) has strong operating leverage to the fast growing health care market.

    Read more »

    ⏸️ Investing

    4 ASX stocks soaring today

    Can these four stocks deliver more gains, or this just a flash in pan?

    Read more »

    a woman
    ⏸️ Investing

    3 reasons health stocks rock and 3 stock ideas

    Over the last five years healthcare stocks have thumped the index - are you missing out on the best sector…

    Read more »

    ⏸️ Investing

    Smart money small-caps: Azure Healthcare Ltd and Money3 Corporation Limited

    Successful small-cap investing will smash the returns available from larger companies - but you have to get it right.

    Read more »

    a woman
    ⏸️ Investing

    Will these companies be Australia's next healthcare giants?

    Nurse call systems may be the next boom industry.

    Read more »

    a woman
    ⏸️ Investing

    Beat the big fund managers with these 3 rocketing microcaps

    These three stocks are up 1,200%, 270%, and 650% - and the market is only just waking up to their…

    Read more »

    ⏸️ Investing

    5 biotech stocks to add excitement to your portfolio

    3 of them are even growing profits at a strong pace

    Read more »

    a woman
    ⏸️ Investing

    3 clever companies for any healthy share portfolio

    CSL, Azure Healthcare and Anteo Diagnostics are all in the business of commercialising the inventions of clever scientists. Better yet,…

    Read more »

    Dividend Payment History Data provided by Morningstar.

    Data provided by Morningstar.
    Ex-Date Amount Franking Type Payable
    02 Mar 2023 $0.0018 100.00% Interim 05 Apr 2023
    16 Sep 2022 $0.0030 100.00% Final 07 Oct 2022

    AHC ASX Announcements

    An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

    DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
    YesNo

    About Austco Healthcare Ltd

    Austco Healthcare Ltd. engages in the development, manufacture, and supply of hardware relating to healthcare and electronic communications systems. It operates through the following geographical segments: Australia/New Zealand, Asia, Europe, and North America. The company was founded by Robert Edward Grey in 2004 and is headquartered in Port Melbourne, Australia.

    AHC Share Price History Data provided by Morningstar.

    Data provided by Morningstar.
    Date Close Change % Change Volume Open High Low
    20 Feb 2026 $0.39 $0.01 2.60% 401,209 $0.39 $0.39 $0.39
    19 Feb 2026 $0.39 $0.06 18.46% 2,081,768 $0.39 $0.39 $0.37
    18 Feb 2026 $0.33 $-0.01 -3.03% 332,707 $0.33 $0.34 $0.32
    17 Feb 2026 $0.33 $0.00 0.00% 894,886 $0.34 $0.35 $0.33
    16 Feb 2026 $0.33 $0.02 6.35% 375,483 $0.32 $0.33 $0.32
    13 Feb 2026 $0.32 $-0.01 -3.08% 950,414 $0.32 $0.33 $0.31
    12 Feb 2026 $0.33 $-0.03 -8.45% 312,564 $0.37 $0.37 $0.32
    11 Feb 2026 $0.36 $-0.01 -2.78% 176,726 $0.36 $0.36 $0.35
    10 Feb 2026 $0.36 $0.01 2.82% 160,005 $0.36 $0.37 $0.36
    09 Feb 2026 $0.36 $0.01 2.86% 33,501 $0.38 $0.38 $0.36
    06 Feb 2026 $0.35 $-0.03 -7.89% 568,896 $0.38 $0.38 $0.35
    05 Feb 2026 $0.38 $0.01 2.70% 152,311 $0.37 $0.38 $0.37
    04 Feb 2026 $0.37 $-0.03 -7.59% 368,386 $0.40 $0.40 $0.37
    03 Feb 2026 $0.40 $0.00 0.00% 337,737 $0.40 $0.40 $0.38
    02 Feb 2026 $0.40 $0.02 5.33% 130,582 $0.37 $0.40 $0.37
    30 Jan 2026 $0.38 $0.01 2.74% 149,733 $0.37 $0.39 $0.37
    29 Jan 2026 $0.37 $0.00 0.00% 304,408 $0.37 $0.37 $0.36
    28 Jan 2026 $0.37 $-0.01 -2.67% 24,164 $0.38 $0.38 $0.37
    27 Jan 2026 $0.38 $0.01 2.74% 462,293 $0.38 $0.38 $0.37
    23 Jan 2026 $0.37 $-0.01 -2.67% 357,539 $0.38 $0.38 $0.37
    22 Jan 2026 $0.38 $0.00 0.00% 129,953 $0.38 $0.38 $0.37

    Director Transactions Data provided by Morningstar.

    Data provided by Morningstar.
    Date Director Type Amount Value Notes
    30 Oct 2025 Clayton Astles Issued 632,649 $275,202
    Employee Share Ownership Plan. 21,31,874 Rrights
    05 Sep 2025 James Brett Burns Buy 59,264 $20,149
    On-market trade.
    31 Jul 2025 Clayton Astles Exercise 575,788 $213,041
    Exercise of options. cashless
    31 Jul 2025 Clayton Astles Issued 575,788 $213,041
    Exercise of options. cashless
    31 Jul 2025 Clayton Astles Expiry 774,212 $286,458
    Options expired.
    28 Mar 2025 Clayton Astles Sell 500,000 $143,748
    On-market trade. average price
    05 Mar 2025 James Brett Burns Sell 149,183 $40,279
    On-market trade.
    05 Mar 2025 James Brett Burns Buy 172,413 $48,275
    On-market trade.

    Directors & Management Data provided by Morningstar.

    Data provided by Morningstar.
    Name Title Start Date Profile
    Mr James Brett Francis Burns Non-Executive Director Oct 2015
    Mr Burns is a corporate governance and legal professional with over 25 years of experience in the field. He has been serving as a Non-Executive Director since October 2015, bringing expertise and strategic insight into his role. Mr Burns is the Managing Partner of CBW Partners, a boutique corporate law firm known for its specialization in mergers and acquisitions, debt and equity capital markets. Throughout his career, Mr Burns has held roles, including senior positions in private practice with prominent national and international law firms, as well as regulatory roles with the Australian Securities and Investments Commission.
    Mr Graeme Ambery Billings Non-Executive ChairmanNon-Executive Director Oct 2015
    Mr Billings retired from PriceWaterhouseCoopers in 2011 after 34 years. He is a former head of the Melbourne assurance practice as well as heading the firm's Australian and global industrial products business. He has had experience providing assurance, transaction and consulting services to multinational and national companies across a variety of industries. Mr Billings is Chairman and Non-Executive Director of Amotiv Limited and Non-Executive Director of Clover Corporation Limited. Graeme also serves as the Chairman of the audit and compliance committee of Clover Corporation Limited. He is the Chair of the Risk Committee.
    Mr Clayton Astles Chief Executive OfficerExecutive Director Aug 2015
    Mr Astles prior to his current role, served as President of Austco Marketing & Services (USA) Ltd., where he played a role in establishing and expanding Austco's operations in the United States. Mr Astles has over 20 years of leadership experience in the healthcare technology industry.
    Mr Anthony James Glenning Non-Executive Director Sep 2018
    Mr Glenning is a Chief Executive and Non-Executive Director with a career spanning 25 years in the software development industry, 14 of those years living and working in Silicon Valley. In 1999, he founded Tonic Systems, a web application development company which he built up over 8 years and sold to Google in 2007 as part of the Google doc suite of products. He transferred to Google post-acquisition where he worked as Senior Software Engineer for two years. From 2010 to 2018, Mr Glenning was an Investment Director for Starfish Ventures, based in Melbourne, a venture capital firm that specialises in Australian high growth technology businesses, and during that time held numerous directorships including at Atmail, Design.com (formerly DesignCrowd), MetaCDN and Nitro Software. Currently, Mr Glenning is a Fund Advisor to Skalata Ventures, investing in early-stage companies.
    Ms Ann Larkins Non-Executive Director Dec 2024
    Mrs Larkins brings a combination of clinical expertise and leadership experience in health IT and digital transformation. As the Executive Director and Chief Information Officer (CIO) at the Australian Red Cross Lifeblood, Mrs Larkins has led initiatives, including cloud migrations, infrastructure uplifts and implementing advanced enterprise systems such as SAP SuccessFactors and Oracle FIMS. Before her role at Lifeblood, Mrs Larkins held senior leadership positions at Barwon Health and Alfred Health, where she led projects as Executive Director and CIO across Health Information Services and ICT Divisions.
    Mr Brendan Maher Chief Operating Officer- ANZChief Financial OfficerCompany Secretary Oct 2018
    -
    Brendan Maher Chief Operating Officer- ANZChief Financial OfficerCompany Secretary
    -

    Top Shareholders Data provided by Morningstar.

    Data provided by Morningstar.
    Name Shares Capital
    HSBC Custody Nominees (Australia) Limited 66,796,041 18.28%
    Asia Pac Holdings Pty Ltd 19,488,748 5.33%
    Asia Pac Technology Pty Ltd 18,681,085 5.11%
    BNP Paribas Nominees Pty Ltd <Hub24 Custodial Serv Ltd> 14,083,871 3.85%
    J P Morgan Nominees Australia Pty Limited 13,341,940 3.65%
    Moat Investments Pty Ltd <Moat Investment A/C> 12,631,219 3.46%
    Dixson Trust Pty Ltd 10,504,433 2.87%
    Asia Pac Holdings Pty Ltd <Asia Pac Holdings A/C> 8,948,764 2.45%
    ABN Amro Clearing Sydney Nominees Pty Ltd <Custodian A/C> 7,617,459 2.08%
    Mast Financial Pty Ltd <A To Z Investment A/C> 7,251,920 1.98%
    Gliocas Investments Pty Ltd <Gliocas Growth Fund A/C> 6,992,803 1.91%
    BNP Paribas Nominees Pty Ltd <Ib Au Noms Retailclient> 6,411,277 1.75%
    Hestfield Pty Ltd <Neil Eaton Family A/C> 5,029,914 1.38%
    Mr Sean Patrick Martin <The Avebury Family A/C> 4,908,484 1.30%
    Mrs Emma Jane Gracey 4,151,987 1.10%
    Asia Pac Technology Pty Ltd <John Bennetts S/F A/C> 4,083,245 1.10%
    Rokatel Pty Ltd 3,888,889 1.10%
    Sean Elias Family Investments Pty Ltd <Sean Elias Family Inv A/C> 3,848,536 1.10%
    BT Advisory Pty Ltd 3,779,527 1.00%
    Asia Pac Holdings Pty Ltd i 3,502,738 1.00%

    Profile

    since

    Note